Treatment of age‐related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4‐year study of treatment outcomes, durability, safety and quality of life (An extension to the MATE randomised controlled trial)
Archana Airody,
Heidi A. Baseler,
Julie Seymour
et al.
Abstract:PurposeData are limited pertaining to the long‐term benefits of aflibercept treatment for neovascular age‐related macular degeneration (nAMD). The aim of this study was to provide outcomes, safety, durability and quality‐of‐life data with aflibercept using a modified treat, extend and fixed regime over 4 years.MethodsProspective, multicentre, single cohort observational study of treatment‐naïve nAMD participants treated with aflibercept as 2‐year extension of the MATE‐trial that compared early and late Treat‐a… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.